Type 2 diabetes. Type 2 diabetes mellitus
Conditions
Interventions
Intervention 1: Intervention group: The intervention group will receive follow-up and education through phone calls by the researcher twice a week. The timing of these calls will be determined in cons
Sponsors
Oroumia University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients with an age range of 18 to 60 years Clinical diagnosis of diabetes based on the physician's opinion, national guidelines and laboratory confirmation Diabetic patients who use any type of oral or injectable drugs Patients with hemoglobin A1C levels between 5.6-8 Having the ability to read and write Having no diagnosed or treated mental illness Having the ability to work with a mobile smart phone
Exclusion criteria
Exclusion criteria: Having secondary complications of diabetes such as acute blood pressure and kidney problems Having other diseases in addition to diabetes simultaneously, such as heart diseases Not using virtual messaging apps
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Level of glycosylated hemoglobin (HbA1c). Timepoint: Before the intervention and up to 7 days after the intervention. Method of measurement: Taking blood samples by nurse researchers and checking the values ??of dependent variables with relevant laboratory kits by the biochemist researcher.;Level of fasting blood sugar. Timepoint: Before the intervention and up to 7 days after the intervention. Method of measurement: Taking blood samples by nurse researchers and checking the values ??of dependent variables with relevant laboratory kits by the biochemist researcher.;Level of fasting blood insulin. Timepoint: Before the intervention and up to 7 days after the intervention. Method of measurement: Taking blood samples by nurse researchers and checking the values ??of dependent variables with relevant laboratory kits by the biochemist researcher. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pancreatic Beta Cell Function (HOMA-ß). Timepoint: Before the intervention and up to 7 days after the intervention. Method of measurement: Taking blood samples by nurse researchers and checking the values of dependent variables with relevant laboratory kits by the biochemist researcher.;Sensitivity and Resistance of Body Cells to Insulin (HOMA-IR). Timepoint: Before the intervention and up to 7 days after the intervention. Method of measurement: Taking blood samples by nurse researchers and checking the values of dependent variables with relevant laboratory kits by the biochemist researcher. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Naser Parizad
Oroumia University of Medical Sciences
Outcome results
None listed